The poor clinical outcome of hepatocellular carcinoma (HCC) patients is ascribed to the
resistance of HCC cells to traditional treatments and tumor recurrence after curative …

Testicular cancer is the most prevalent tumor among males aged 15 to 35, resulting in a
significant number of newly diagnosed cases and fatalities annually. Non-coding RNAs …

Background CircRNA myosin light chain kinase (circRNA MYLK) has been shown to
promote the progression of various tumor diseases. The purpose of this study was to explore …

Cancer ranks as the second leading cause of death worldwide, causing a large social and
economic burden. However, most anti-cancer treatments face the problems of tumor …

Abstracts Backgrounds LncRNA Brain Cytoplasmic RNA 1 (BCYRN1) has been certified to
modulate cancer cells growth and aggressiveness in several tumors. However, research …

Undifferentiated embryonal sarcoma of the liver (UESL) is a rare and aggressive
malignancy. Though the molecular underpinnings of this cancer have been largely …

Introduction The chromosome 19 miRNA cluster (C19MC) encodes a large family of
microRNAs (miRNAs) that are abundantly expressed in the placenta of higher primates and …

A percentage of celiac disease (CD) patients develop refractory type-2 disease (RCD2), a
condition associated with increased risk of enteropathy-associated T-cell-lymphoma (EATL) …

Background Despite significant improvement in screening programs for cancers of the
respiratory district, especially in at-risk subjects, early disease detection is still a major issue …

MYO18B has been proposed to contribute to the progression of hepatocellular carcinoma
(HCC). However, the signals that govern MYO18B transcription are not known. Here we …